Montelukast Torrent Pharma (Uk) (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes from binding. This inhibition stops the cascade that leads to bronchoconstriction, mucus production, and airway inflammation, thereby improving breathing and reducing allergic nasal symptoms.

The appropriate dose of Montelukast Torrent Pharma is determined by the prescribing clinician based on the patient’s age, weight, and specific condition. Dosage recommendations are individualized and should follow the healthcare professional’s instructions.

Safety data for Montelukast in pregnancy and lactation are limited. Clinicians weigh potential benefits against risks before prescribing to pregnant or nursing individuals. Patients should discuss their situation with a healthcare provider to make an informed decision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑exacerbated respiratory disease or those who need an adjunct to inhaled therapy, though it does not replace rescue bronchodilators.

Montelukast Torrent Pharma should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

The medication is taken orally, usually once daily in the evening, with or without food. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed by a healthcare professional.

Serious concerns include neuropsychiatric events such as depression, agitation, or suicidal thoughts, as well as rare allergic reactions like angioedema and anaphylaxis. Patients should seek immediate medical attention if they experience mood changes, rash, or breathing difficulties.

Montelukast is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. It should be used with caution in patients with severe hepatic impairment and is not recommended for acute asthma attacks where rapid bronchodilation is required.